SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-006588
Filing Date
2019-05-08
Accepted
2019-05-08 17:02:33
Documents
56
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 566230
2 ex31-1.htm EX-31.1 17118
3 ex31-2.htm EX-31.2 16988
4 ex32-1.htm EX-32.1 6290
5 ex32-2.htm EX-32.2 6452
  Complete submission text file 0001493152-19-006588.txt   2538866

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE prvb-20190331.xml EX-101.INS 340704
7 XBRL SCHEMA FILE prvb-20190331.xsd EX-101.SCH 35221
8 XBRL CALCULATION FILE prvb-20190331_cal.xml EX-101.CAL 31167
9 XBRL DEFINITION FILE prvb-20190331_def.xml EX-101.DEF 133524
10 XBRL LABEL FILE prvb-20190331_lab.xml EX-101.LAB 212187
11 XBRL PRESENTATION FILE prvb-20190331_pre.xml EX-101.PRE 187046
Mailing Address P.O. BOX 666 OLDWICK NJ 08858
Business Address P.O. BOX 666 OLDWICK NJ 08858 908-428-9136
Provention Bio, Inc. (Filer) CIK: 0001695357 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38552 | Film No.: 19807521
SIC: 2834 Pharmaceutical Preparations